Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.1 USD | -0.73% | -2.72% | +3.38% |
Business Summary
Number of employees: 373
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Enzymes and Devices
100.0
%
| 660 | 100.0 % | 829 | 100.0 % | +25.62% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
70.8
%
| 438 | 66.4 % | 587 | 70.8 % | +34.07% |
Switzerland
18.0
%
| 167 | 25.3 % | 149 | 18.0 % | -10.68% |
Belgium
7.0
%
| 2 | 0.3 % | 58 | 7.0 % | +2,694.73% |
All Other Foreign
2.4
%
| 5 | 0.8 % | 20 | 2.4 % | +272.23% |
Japan
1.8
%
| 48 | 7.3 % | 15 | 1.8 % | -68.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 61 | 14-01-05 |
Nicole LaBrosse
DFI | Director of Finance/CFO | 41 | 14-12-31 |
Mark Snyder
CMP | Compliance Officer | 57 | 22-01-02 |
Steve Knowles
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Michael LaBarre
CTO | Chief Tech/Sci/R&D Officer | 60 | 08-06-15 |
Tram Bui
IRC | Investor Relations Contact | - | 21-12-31 |
Amy Marinne Fox
HRO | Human Resources Officer | - | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
BRD | Director/Board Member | 70 | 06-07-30 |
Chairman | 59 | 15-08-04 | |
Barbara Duncan
BRD | Director/Board Member | 59 | 23-02-02 |
Helen Torley
CEO | Chief Executive Officer | 61 | 14-01-05 |
Matthew Posard
BRD | Director/Board Member | 56 | 13-03-27 |
Jean Bizzari
BRD | Director/Board Member | 69 | 15-01-16 |
Director/Board Member | 68 | 22-03-14 | |
Director/Board Member | 65 | 18-09-09 | |
Nicole LaBrosse
DFI | Director of Finance/CFO | 41 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 127,054,240 | 125,682,266 ( 98.92 %) | 0 | 98.92 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.38% | 4.88B | |
-3.24% | 102B | |
+3.29% | 96.09B | |
-1.02% | 22.05B | |
-17.99% | 20.81B | |
-6.87% | 19.06B | |
-40.70% | 16.05B | |
-26.57% | 14.01B | |
+1.98% | 13.38B | |
+22.46% | 11.01B |
- Stock Market
- Equities
- HALO Stock
- Company Halozyme Therapeutics, Inc.